Literature DB >> 21607145

Pancreatic secretory trypsin inhibitor: More than a trypsin inhibitor.

Gai-Ping Wang1, Cun-Shuan Xu.   

Abstract

Kazal-type serine protease inhibitor is one of the most important and widely distributed protease inhibitor families. Pancreatic secretory trypsin inhibitor (PSTI), also known as serine protease inhibitor Kazal type I(SPINK1), binds rapidly to trypsin, inhibits its activity and is likely to protect the pancreas from prematurely activated trypsinogen. Therefore, it is an important factor in the onset of pancreatitis. Recent studies found that PSTI/SPINK1 is also involved in self-regulation of acinar cell phagocytosis, proliferation and growth of a variety of cell lines. In addition, it takes part in the response to inflammatory factor or injury and is highly related to adult type II citrullinemia.

Entities:  

Keywords:  Adult-II citrullinemia.; Autophagy; Cell proliferation; Inflammatory factor; Pancreatic secretory trypsin inhibitor/serine protease inhibitor Kazal type I; Pancreatitis

Year:  2010        PMID: 21607145      PMCID: PMC3097947          DOI: 10.4291/wjgp.v1.i2.85

Source DB:  PubMed          Journal:  World J Gastrointest Pathophysiol        ISSN: 2150-5330


  44 in total

1.  Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis.

Authors:  H Witt; W Luck; H C Hennies; M Classen; A Kage; U Lass; O Landt; M Becker
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

2.  Purification, characterization and amino-acid sequencing of two pancreatic secretory trypsin inhibitors in rat pancreatic juice.

Authors:  K Uda; M Ogawa; T Shibata; A Murata; T Mori; N Kikuchi; N Yoshida; S Tsunasawa; F Sakiyama
Journal:  Biol Chem Hoppe Seyler       Date:  1988-05

3.  Distribution of pancreatic secretory trypsin inhibitor in various human tissues and its inactivation in the gastric mucosa.

Authors:  T Shibata; M Ogawa; N Takata; K Matsuda; T Niinobu; K Uda; C Wakasugi; T Mori
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1987-02

4.  SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis.

Authors:  R H Pfützer; M M Barmada; A P Brunskill; R Finch; P S Hart; J Neoptolemos; W F Furey; D C Whitcomb
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

5.  Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis.

Authors:  J P H Drenth; R te Morsche; J B M J Jansen
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

6.  Evaluation of TATI and other markers in solid tumors.

Authors:  W Taccone; W Mazzon; M Belli
Journal:  Scand J Clin Lab Invest Suppl       Date:  1991

7.  Identification of the IL-6-responsive element in an acute-phase-responsive human pancreatic secretory trypsin inhibitor-encoding gene.

Authors:  T Yasuda; M Ogawa; A Murata; Y Ohmachi; T Yasuda; T Mori; K Matsubara
Journal:  Gene       Date:  1993-09-15       Impact factor: 3.688

8.  The bifunctional rat pancreatic secretory trypsin inhibitor/monitor peptide provides protection against premature activation of pancreatic juice.

Authors:  R Graf; S Klauser; S-I Fukuoka; M Schiesser; D Bimmler
Journal:  Pancreatology       Date:  2003       Impact factor: 3.996

9.  Extrapancreatic origin of the pancreatic secretory trypsin inhibitor as an acute-phase reactant.

Authors:  P Jönsson; C Linder; S Genell; K Ohlsson
Journal:  Pancreas       Date:  1996-04       Impact factor: 3.327

10.  Specific expression of the pancreatic-secretory-trypsin-inhibitor (PSTI) gene in hepatocellular carcinoma.

Authors:  Y Ohmachi; A Murata; N Matsuura; T Yasuda; T Yasuda; M Monden; T Mori; M Ogawa; K Matsubara
Journal:  Int J Cancer       Date:  1993-11-11       Impact factor: 7.396

View more
  5 in total

1.  SPINK1 Promoter Variants Are Associated with Prostate Cancer Predisposing Alterations in Benign Prostatic Hyperplasia Patients.

Authors:  Danyelle Winchester; Luisel Ricks-Santi; Tshela Mason; Muneer Abbas; Robert L Copeland; Desta Beyene; Emmanuel Y Jingwi; Georgia M Dunston; Yasmine M Kanaan
Journal:  Anticancer Res       Date:  2015-07       Impact factor: 2.480

2.  Gene Signature of the Human Pancreatic ε Cell.

Authors:  Giselle Dominguez Gutierrez; Jinrang Kim; Ann-Hwee Lee; Jenny Tong; JingJing Niu; Sarah M Gray; Yi Wei; Yueming Ding; Min Ni; Christina Adler; Andrew J Murphy; Jesper Gromada; Yurong Xin
Journal:  Endocrinology       Date:  2018-12-01       Impact factor: 4.736

3.  Regulation of the Pancreatic Exocrine Differentiation Program and Morphogenesis by Onecut 1/Hnf6.

Authors:  Peter A Kropp; Xiaodong Zhu; Maureen Gannon
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2019-03-01

4.  Transcriptomic features of primary prostate cancer and their prognostic relevance to castration-resistant prostate cancer.

Authors:  Seok Joong Yun; Seon-Kyu Kim; Jayoung Kim; Eun-Jong Cha; Jang-Seong Kim; Sun-Jin Kim; Yun-Sok Ha; Ye-Hwan Kim; Pildu Jeong; Ho Won Kang; Jeong-Hwan Kim; Jong-Lyul Park; Young-Ki Choi; Sung-Kwon Moon; Yung-Hyun Choi; Seon-Young Kim; Wun-Jae Kim
Journal:  Oncotarget       Date:  2017-11-06

5.  Influence of the MUC1 Cell Surface Mucin on Gastric Mucosal Gene Expression Profiles in Response to Helicobacter pylori Infection in Mice.

Authors:  Yong H Sheng; Garrett Z Ng; Kim M Summers; Alison L Every; Gareth Price; Sumaira Z Hasnain; Philip Sutton; Michael A McGuckin
Journal:  Front Cell Infect Microbiol       Date:  2020-07-24       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.